Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | NPC1 | O15118 | 4/20 | 0.41 |
| ▸ | RAB9A | P51151 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.41 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA4 | P22748 | 2/20 | 0.40 |
| ▸ | CA6 | P23280 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL980499 | 0.76 | AOC3 (0.54) | ALDH1A1NPC1RAB9AKDM4EMAPT | |
| SCHEMBL30041175 | 0.76 | AOC3 (0.54) | ALDH1A1NPC1RAB9AKDM4EMAPT | |
| Methane SCHEMBL27716118 | 0.74 | AOC3 (0.52) | ALDH1A1NPC1RAB9AKDM4EMAPT | |
| SCHEMBL12003943 | 0.74 | AOC3 (0.52) | ALDH1A1NPC1RAB9AKDM4EMAPT | |
| SCHEMBL30010158 | 0.73 | ALDH1A1 (0.45) | ALDH1A1NPC1RAB9AKDM4EMAPT | |
| 2-Phenyl-1H-Indole SCHEMBL29581436 | 0.70 | NPC1 (0.64) | ALDH1A1NPC1RAB9AKDM4EMAPT | |
| SCHEMBL29139308 | 0.70 | KDM4E (0.47) | ALDH1A1NPC1RAB9AKDM4EMAPT | |
| SCHEMBL27556311 | 0.67 | DAO (0.47) | ALDH1A1NPC1RAB9AKDM4EMAPT | |
| Phosphoric Acid SCHEMBL18344261 | 0.67 | FLT3 (0.48) | ALDH1A1NPC1RAB9AKDM4EMAPT | |
| SCHEMBL31465196 | 0.66 | TUBB4A (0.37) | ALDH1A1NPC1RAB9AKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124174-A1 | COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI THERAPEUTICS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260115168-A1 | COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260115167-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-12472163-B2 | Compositions of matter and pharmaceutical compositions | ATAI THERAPEUTICS, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| US-12396982-B2 | Compositions of matter and pharmaceutical compositions | ATAI THERAPEUTICS, INC. (US) | 2025-08-26 | — | — | US | disclosed |
| US-20250235428-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | PSILERA INC. | 2025-07-24 | — | — | US | disclosed |
| US-20250064783-A1 | Compositions of Matter and Pharmaceutical Compositions | PSILERA INC. | 2025-02-27 | — | — | US | disclosed |
| US-20250041273-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI LIFE SCIENCES N.V. (DE) | 2025-02-06 | — | — | US | disclosed |
| US-12053453-B2 | Compositions of matter and pharmaceutical compositions | PSILERA INC. (US) | 2024-08-06 | — | — | US | disclosed |
| US-20230372295-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI THERAPEUTICS, INC. | 2023-11-23 | — | — | US | disclosed |
| US-11759452-B2 | Compositions of matter and pharmaceutical compositions | PSILERA INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-20220354824-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI THERAPEUTICS, INC. | 2022-11-10 | — | — | US | disclosed |
| US-11478449-B1 | Compositions of matter and pharmaceutical compositions | PSILERA INC. (US) | 2022-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115168-A1 | COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | PNMT, HTR5A, TPH2 | ALDH1A1 3346/4885NPC1 467/4885RAB9A 1114/4885 |
| US-20250235428-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | TPH1, HTR2C, HTR1B | ALDH1A1 3556/4885NPC1 797/4885RAB9A 2152/4885 |
| US-11478449-B1 | Compositions of matter and pharmaceutical compositions | TPH1, HTR1B, HTR2C | ALDH1A1 3634/4885NPC1 511/4885RAB9A 2004/4885 |
| US-20250064783-A1 | Compositions of Matter and Pharmaceutical Compositions | TPH1, HTR1B, HTR2C | ALDH1A1 3634/4885NPC1 511/4885RAB9A 2004/4885 |
| US-12472163-B2 | Compositions of matter and pharmaceutical compositions | TPH1, HTR1B, HTR2C | ALDH1A1 3634/4885NPC1 511/4885RAB9A 2004/4885 |
| US-20260115167-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | HTR2C, HTR5A, TPH2 | ALDH1A1 3719/4885NPC1 860/4885RAB9A 1285/4885 |
| US-20250041273-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | TPH1, HTR2C, HTR1B | ALDH1A1 3556/4885NPC1 797/4885RAB9A 2152/4885 |
| US-20230372295-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | TPH1, HTR2C, HTR1B | ALDH1A1 3556/4885NPC1 797/4885RAB9A 2152/4885 |
| US-20220354824-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | TPH1, HTR2C, HTR1B | ALDH1A1 3556/4885NPC1 797/4885RAB9A 2152/4885 |
| US-11759452-B2 | Compositions of matter and pharmaceutical compositions | TPH1, HTR1B, HTR2C | ALDH1A1 3634/4885NPC1 511/4885RAB9A 2004/4885 |
| US-20260124174-A1 | COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | MAOB, TPH1, TPH2 | ALDH1A1 1586/4885NPC1 262/4885RAB9A 2243/4885 |
| US-12053453-B2 | Compositions of matter and pharmaceutical compositions | TPH1, HTR1B, HTR2C | ALDH1A1 3634/4885NPC1 511/4885RAB9A 2004/4885 |
| US-12396982-B2 | Compositions of matter and pharmaceutical compositions | TPH1, HTR1B, HTR2C | ALDH1A1 3634/4885NPC1 511/4885RAB9A 2004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.